Completed PHASE2 INTERVENTIONAL 2-arm NCT00576108

A 2 Week Study of Topical KD7040 in the Treatment of Postherpetic Neuralgia (PHN)

Sponsor: Kalypsys, Inc.

Conditions Herpes Zoster Neuropathic Pain Postherpetic Neuralgia Shingles

Interventions KD7040 Topical Gel Placebo gel

Updated 6 times since 2017 Last updated: Jul 18, 2008 Started: Nov 30, 2007 Primary completion: Jul 31, 2008 Completion: Jul 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Herpes Zoster and Neuropathic Pain and is currently completed. Kalypsys, Inc. leads this study, which shows 6 recorded versions since 2007 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Feb 2017 — Jun 2018 [monthly]

Completed PHASE2

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

Nov 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Kalypsys, Inc.

Data source: Kalypsys, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kansas City, United States